Glucose conjugation for the specific targeting and treatment of cancer
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Cancers of diverse origins exhibit marked glucose avidity and high rates of aerobic glycolysis. Increased understanding of this dysfunctional metabolism known as the Warburg effect has led to an interest in targeting it for cancer therapy. One promising strategy for such targeting is glycoconjugation, the linking of a drug to glucose or another sugar. This review summarizes the most salient examples of glycoconjugates, in which known cytotoxins or targeted anticancer therapeutics have been linked to glucose (or another glucose transporter substrate sugar) for improved cancer targeting and selectivity. Building on these examples, this review also provides a series of guidelines for the design and mechanistic evaluation of future glycoconjugates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“Today this phenomenon is known as the Warburg effect and is recognized as one of the hallmarks of cancer [3].”
BackgroundWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“Almost a century ago, the German scientist Otto Warburg observed that cancerous tissues consume large amounts of glucose compared to non-transformed tissue and have high rates of aerobic glycolysis [1, 2].”
BackgroundThe metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416 · cited 1×
“Almost a century ago, the German scientist Otto Warburg observed that cancerous tissues consume large amounts of glucose compared to non-transformed tissue and have high rates of aerobic glycolysis [1, 2].”
BackgroundTrastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834 · cited 1×
“Another antibody-drug conjugate, Kadcyla (trastuzumab emtansine; Figure 2b), received US FDA approval in February 2013 for the treatment of HER2-positive breast cancer following the EMILIA clinical trial [15].”
BackgroundTargeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411 · cited 1×
“Most efforts have focused on using small molecules to inhibit the function of metabolic enzymes, as comprehensively reviewed elsewhere [10, 11].”
BackgroundParker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197 · cited 1×
“For this reason, folate receptor α (FR-α) is overexpressed in an estimated 40% of human cancers (it is expressed only by certain types of epithelial cells in healthy individuals) [17, 18].”
BackgroundDe Vivo, D. C., Trifiletti, R. R., Jacobson, R. I., Ronen, G. M., Behmand, R. A., & Harik, S. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251006 · Cited by 800 · cited 1×
“Incidentally, humans born with a mutated, functionallyimpaired GLUT-1 transporter experience a severe phenotype known as De Vivo disease which results in mental retardation, seizures, and a host of neurological deficits, underscoring the importance of GLUT-1 in supplying glucose to the nervous system [95].”
BackgroundSenter, P. D., & Sievers, E. L. (2012) · Nature Biotechnology · doi:10.1038/nbt.2289 · Cited by 763 · cited 1×
“Adcertis is thought to enter cancer cells via CD30 receptor-mediated endocytosis and subsequently be trafficked to endosomes, where a combination of degradative enzymes and increased acidity lead to cleavage to the active tubulin inhibitor [14].”
BackgroundGenes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 659 · cited 1×
“Glycolytic enzymes, as well as the insulinindependent glucose transporter GLUT-1, are widely overexpressed in human cancers [4, 5], and high expression levels of these proteins in tumor biopsy samples correlate with poor cancer prognosis, making them attractive therapeutic targets [6–9].”
BackgroundFolate-targeted therapeutic and imaging agents for cancer
Low, P. S., & Kularatne, S. A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.022 · Cited by 585 · cited 1×
“For this reason, folate receptor α (FR-α) is overexpressed in an estimated 40% of human cancers (it is expressed only by certain types of epithelial cells in healthy individuals) [17, 18].”
Background
Cited by
Items 301–400 of 401
Dadpour, S., Mashreghi, M., Shahraki, N., Mehrabian, A., Moosavian, S. A., & Jaafari, M. R. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.104006 · Cited by 3
Stereoselective C1-Arylation of Native Sugars via Ligand-Promoted Nickel Catalysis
Lu, H., Li, Y., Ma, N., Chen, R., Wang, Y., Chen, M., Zhang, W., Wang, X., Jin, H., Ding, C., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c06488 · Cited by 3
Tao, X., Chen, L., Jiang, Q., Zhang, X., Wu, J., & Dai, Y. (2026) · Organic Letters · doi:10.1021/acs.orglett.6c02623 · Cited by 3
Pors, M. S. L., de la Parra, L. S. M., Riafrecha, L. E., Vullo, D., León, I. E., Supuran, C. T., & Colinas, P. A. (2023) · ChemistrySelect · doi:10.1002/slct.202300039 · Cited by 3
Soldevila‐Barreda, J. J., Pettenuzzo, A., Azmanova, M., Rafols, L., Attia, A. A. A., Lupan, A., Ronconi, L., Barry, N. P. E., & Pitto‐Barry, A. (2023) · Helvetica Chimica Acta · doi:10.1002/hlca.202300064 · Cited by 3
Zuo, H., Zhang, C., Zhang, Y., & Niu, D. (2023) · Angewandte Chemie · doi:10.1002/ange.202309887 · Cited by 3
Redjdal, W., Benmahdjoub, S., Luong, T. T. H., Benmerad, B., Bideau, F. L., Vergnaud, J., & Messaoudi, S. (2024) · ChemMedChem · doi:10.1002/cmdc.202400195 · Cited by 3
Li, X., Zhang, H., Dong, S., Gao, X., Sun, H., Zhou, Z., Hu, K., Guo, S., Zhang, Q., Guo, Z., et al. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117843 · Cited by 3
Hayat, K., Nixon, G. L., Zhang, Q., & Matziari, M. (2024) · ACS Omega · doi:10.1021/acsomega.4c05988 · Cited by 3
Leparfait, D., Mahé, A., Feng, X., Coupri, D., Cavelier, F. L., Verneuil, N., Pfund, E., Budin‐Verneuil, A., & Lequeux, T. P. (2025) · Molecules · doi:10.3390/molecules30122569 · Cited by 3
Copper-free click functionalization of glucose-derived carbon spheres for tumor targeting
Gessner, I., Krakor, E., Styrnol, S., Klimpel, A., Neundorf, I., & Mathur, S. (2019) · MRS Advances · doi:10.1557/adv.2019.488 · Cited by 3
Investigations into the Aqueous Synthesis of Selenoglycoconjugates
Lim, D., & Paradisi, F. (2023) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202300496 · Cited by 3
Glycomimetics and Glycoconjugates in Drug Discovery
Xavier, N. M., & Andreana, P. R. (2024) · Pharmaceuticals · doi:10.3390/ph17030323 · Cited by 3
“…levels of oxygen (hypoxia) and nutrients as well as their higher energy demand due to inappropriate proliferation lead to an increase in glucose uptake and GLUT overexpression [11], and therefore linking glucose to a cytotoxic compound is a strategy to increase cancer-cell-selective targeting [12].”
BackgroundAyoup, M. S., Awad, L. F., Negm, A., Nawah, J. Y. A., Kassab, A. E., & Elghamry, I. (2025) · ChemistrySelect · doi:10.1002/slct.202500187 · Cited by 3
Driedger, D., Fers-Lidou, A., Schroeder, M. D., Elisia, I., Krystal, G., & Britton, R. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c08176 · Cited by 3
Pors, M. S. L., Barri, I. A., Riafrecha, L. E., Echeverría, G. A., Piro, O. E., & Colinas, P. A. (2022) · ChemistrySelect · doi:10.1002/slct.202104379 · Cited by 3
Karmakar, S., Bhattacharyya, S., & Mukherjee, A. (2016) · Journal of Chemical Sciences · doi:10.1007/s12039-015-1019-3 · Cited by 3
Preferential uptake of glucose-functionalized liposomes by cancer cells
Tzror-Azankot, C., Sadan, T., Atkins, A., Motiei, M., & Popovtzer, R. (2022) · Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications · doi:10.1117/12.2608826 · Cited by 3
Shi, B.-Y., Wang, Z.-H., Zhang, N., Xie, Y.-R., Sun, X., Yang, H., Wu, Y.-L., Zi, C., Wang, X., & Sheng, J. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-021-02726-5 · Cited by 3
Developing Ligands to Target Transition Metals in Cancer
Utterback, R. D., & Tomat, E. (2019) · Wiley eBooks · doi:10.1002/9781119951438.eibc2694 · Cited by 7
Glycosidase-activated prodrugs of a cytotoxic iron chelator for targeted cancer therapy
Tomar, D., Steinbrueck, A., Sedgwick, A. C., Levine, M. S., Sessler, J. L., & Metzler‐Nolte, N. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00232j · Cited by 2
Khmelevskaya, E. A., Danilkina, N. A., Silonov, S. A., Tretyakov, E. V., Khlebnikov, A. F., Melnikov, V. E., Nikitina, A. V., Rumyantsev, A. M., Kryukova, M. A., & Balova, I. A. (2025) · Organic & Biomolecular Chemistry · doi:10.1039/d5ob01600b · Cited by 2
Bononi, G., Paltrinieri, E., Fortunato, S., Cicio, G., Giovanni, N. D., Lencioni, G., Funel, N., Giovannetti, E., Granchi, C., Bussolo, V. D., et al. (2025) · Molecules · doi:10.3390/molecules31010028 · Cited by 2
“The β -glucopyranose unit was chosen as a glucose mimic, as it has been widely shown to be potentially recognized by the glucose transporters (Figure 2A) [12].”
Li, B., Luo, Q., Luo, K., Lu, W., Zeng, S., Yang, M., & Liu, T. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109434 · Cited by 2
Glycosidase-activated H2S donorsto enhance chemotherapy efficacy
Ye, Z., Li, J., Shi, J., Song, Y., Liu, Y., & Hou, J. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129644 · Cited by 2
Song, Y. H., Cho, H. M., Ryu, Y. C., Hwang, B. H., & Seo, J. H. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c18774 · Cited by 2
Synthesis and Cytotoxic Evaluation of Glucoconjugated Ethylmompain Derivatives
Pokhilo, N. D., Atopkina, L. N., Киселева, М. И., Денисенко, В. А., & Ануфриев, В. Ф. (2017) · Natural Product Communications · doi:10.1177/1934578x1701200924 · Cited by 2
“undergoing advanced clinical trials and many others are in preclinical development [6].”
Liu, J., Wu, C., Jin, H.-M., Du, K., & Zheng, H. (2019) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.3707 · Cited by 2
Harnessing GLUT1‐Targeted Pro‐oxidant Ascorbate for Synergistic Phototherapeutics
Koo, S., Lee, M., Sharma, A. K., Li, M., Zhang, X., Pu, K., Chi, S., & Kim, J. S. (2022) · Angewandte Chemie · doi:10.1002/ange.202110832 · Cited by 2
Synthesis, Antimicrobial and Mutagenic Activity of a New Class of d-Xylopyranosides
Sikora, K., Szweda, P., Słoczyńska, K., Samaszko-Fiertek, J., Madaj, J., Liberek, B., Pękala, E., & Dmochowska, B. (2023) · Antibiotics · doi:10.3390/antibiotics12050888 · Cited by 2
“It can be influenced by many factors, such as the structure of the sugar compound, the type of its substitution or even the type of aglycone [27,28].”
BackgroundWu, Z., Ma, J., Brownell, A., Wang, H., Li, C., Meng, X., Yuan, L., Liu, H., Li, S., & Xie, J. (2018) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2018.08.002 · Cited by 2
Cellular internalization pathways of glucose-functionalized gold nanoparticles
Tzror-Azankot, C., Dreifuss, T., Ben-Gal, T.-S., Jacob, A., Sadan, T., Motiei, M., & Popovtzer, R. (2019) · Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications · doi:10.1117/12.2509605 · Cited by 2
Synthesis and Cytotoxicities of Novel Podophyllotoxin Xyloside Derivatives
Zi, C., Yang, L., Zhang, B.-L., Li, Y., Ding, Z., Jiang, Z., Hu, J., & Zhou, J. (2019) · Natural Product Communications · doi:10.1177/1934578x19860668 · Cited by 2
The Present and Future of Optical Imaging Technologies in the Clinic: Diagnosis and Therapy
Stater, E. P., Skubal, M., Tamura, R., & Grimm, J. (2019) · Topics in medicinal chemistry · doi:10.1007/7355_2019_84 · Cited by 3
Hossain, F., Nishat, S., & Andreana, P. R. (2022) · Peptide Science · doi:10.1002/pep2.24260 · Cited by 2
Ferreira, S., Rijo, P. M., Costa, J. G., Saraiva, N., Santos, B. T., Uriel, C., Gómez, A. M., Díaz-Lanza, A. M., & Fernandes, A. S. (2023) · Biomedical and Biopharmaceutical Research · doi:10.19277/bbr.20.1.305 · Cited by 1
Li, N., Hu, B., Du, K., Cao, Y., Zhang, Z., Guo, B., Liu, C., Chu, S., Gao, J., Wang, C., et al. (2025) · Journal of Carbohydrate Chemistry · doi:10.1080/07328303.2025.2468188 · Cited by 1
“[18] Glucose conjugates, previously reported by our group [19] and others, [20,21] such as cytotoxic drugs 1 – 3 in Fig.”
Easy access to a self-assembled glycolipid derived from bhilawanol: a promising anti-cancer drug
Banoo, T., Sandhu, K., Chockalingam, S., & Nagarajan, S. (2025) · Chemical Communications · doi:10.1039/d5cc01621e · Cited by 1
Szreder, J., Woźniak, K., Erfurt, K., Grymel, M., & Pastuch-Gawołek, G. (2025) · Cancers · doi:10.3390/cancers17111737 · Cited by 2
“The ability of GLUT to bind and transport glycoconjugates may be influenced by several factors, such as the carbohydrate structure, the position of its substitution and the linker type [46–48].”
Glucose‐Modified Porphyrins With Superior Photostability for Enhanced Photodynamic Therapy
Zhang, W., Hou, B., Zhang, W., Wang, B., Yang, Z., Jin, N., & Liu, J. (2025) · Applied Organometallic Chemistry · doi:10.1002/aoc.70357 · Cited by 2
Complexation of siRNA with Galactose-Functionalized Dendrimers: PAMAM vs PETIM
Maity, T., Kumar, Y., & Maiti, P. K. (2025) · Langmuir · doi:10.1021/acs.langmuir.5c03613 · Cited by 1
Glucosamine and Galactosamine Functionalised Silica Nanoparticles for the Targeting of Glycoproteins
Hardmeier, M. S. E., Dziemidowicz, K., Williams, G. R., & Davies, G. (2025) · Journal of Cluster Science · doi:10.1007/s10876-025-02947-3 · Cited by 1
“Calvaresi et al. highlighted the use of glucose to deliver small molecules by exploiting the Warburg effect and the preferential glucose uptake by cancer cells [28].”
Jiang, C., Bandyopadhyay, S., Kincanon, M. M., Wo, A., Tedford, E. M., East, A. K., Marcellus, M., Murphy, C. J., & Chan, J. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c25469 · Cited by 1
Singh, D. (2026) · Carbohydrate Research · doi:10.1016/j.carres.2026.110029 · Cited by 1
Efficient glycosylation of natural Danshensu and its enantiomer by sugar and 2-deoxy sugar donors
Sidoryk, K., Cmoch, P., Świtalska, M., Trzaskowski, B., Wietrzyk, J., & Cybulski, M. (2018) · Carbohydrate Research · doi:10.1016/j.carres.2018.02.005 · Cited by 1
Funes-Rivera, S., Kennedy, M. L., Galeano, A. K., Funes, P., & Campuzano-Bublitz, M. Á. (2023) · Biomedical and Biopharmaceutical Research · doi:10.19277/bbr.20.1.311 · Cited by 1
Mishra, V. K., Khanna, A., Tiwari, G., Yadav, Y., & Sagar, R. (2024) · ChemistrySelect · doi:10.1002/slct.202402791 · Cited by 1
GLUT3 enhances chemosensitivity in glioblastoma by transporting temozolomide and capecitabine
Diao, H., Sun, Y., Zhou, X., Wang, Q., Wang, M., Chen, K., Huang, Z., Wei, J., Li, Z., Lou, Y., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02664-w · Cited by 2
Cytotoxicity and Uptake of Lafoensia pacari Extract in Mammary Carcinoma Cells
Atherino, M. C., Reichert, C. L., Atherino, J. C., Pontarolo, R., Concentino, V., Junkert, A. M., Schiefer, E. M., Santos, A. F., Felipe, K. B., & de Souza, W. M. (2020) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-020-00034-4 · Cited by 3
“Glycosylated ellagic acid compounds may be transported by glucose transporters, as cancer cells have been shown to increase expression of glucose transporters to meet the increased energy demands resulting from high proliferation rates (Calvaresi and Hergenrother 2013).”
BackgroundLipopolyplex-based delivery system for cancer vaccine delivery
Kaur, J., Taleuzzaman, M., Das, V., & Singh, A. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823686-4.00013-6 · Cited by 1
Glycoconjugated Metallohelices have Improved Nuclear Delivery and Suppress Tumour Growth In Vivo
Song, H. L., Allison, S. J., Brabec, V., Bridgewater, H. E., Kašpárková, J., Kostrhunová, H., Novohradský, V., Phillips, R. M., Prachařová, J., Rogers, N. J., et al. (2020) · Angewandte Chemie · doi:10.1002/ange.202006814 · Cited by 1
Synthesis and self-assembly of polysaccharide-b-elastin-like polypeptide bioconjugates
Xiao, Y. (2019) · theses.fr (ABES) · doi:10.70675/6ef63cffzc57fz4b2azaedcz5d50202fdccb · Cited by 2
Saeidnia, S. (2014) · SpringerBriefs in pharmaceutical science & drug development · doi:10.1007/978-3-319-14027-8_6
Seasonal Changes in Starch Content in Trophopods ofMatteuccia struthiopteris
Hovenkamp, P., Yan, S., & Choi, Y. H. (2016) · American Fern Journal · doi:10.1640/0002-8444-106.3.153
Working Towards a Cancer Cell Selective and Brain Penetrating Anti Glioma Drug
Middleton, K. N. (2016)
Fluorescent Probe Development for Fructose Specific Transporters in Cancer
Fedie, J. R. (2017) · doi:10.37099/mtu.dc.etdr/332
“Glycoconjugation provides a potentially elegant way of preferentially targeting cancerous cells in the presence of normal, healthy cells by targeting the overactive metabolism of cancer [14].”
InfluentialCharacterising the Biological Activity of a Trichlorovinyl Cysteine-Containing Mycothiol Analogue
Harmos, P. (2018) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17069144.v1
ChemInform Abstract: Glucose Conjugation for the Specific Targeting and Treatment of Cancer
Calvaresi, E. C., & Hergenrother, P. J. (2013) · ChemInform · doi:10.1002/chin.201338262
Prodrugs activated by implantable microsystems
Norman, D. J. (2019) · ERA
Zi, C., Shi, B.-Y., Wang, Z.-H., Zhang, N., Xie, Y.-R., Sun, X., Yang, H., Wu, Y.-L., Wang, X., & Sheng, J. (2021) · Research Square · doi:10.21203/rs.3.rs-182372/v1
[Review] Towards Clinical Application of L-Glucose
Yamada, K. (2022) · Bulletin of Applied Glycoscience · doi:10.5458/bag.12.3_140
Design, Synthesis, and Biological Applications of Boron-Containing Polyamine and Sugar Derivatives
Aoki, S., Ueda, H., Tanaka, T., Itoh, T., Suzuki, M., & Sakurai, Y. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105998
Synthesis of New Glycosylamine Derivatives based on Carbohydrates
Jabbari, H. (2023) · Current Bioactive Compounds · doi:10.2174/1573407219666230810094657
Synthesis and In Vitro Anti-tumor Evaluation of Novel Glycoconjugated SN38 Derivatives
Wang, X., Yang, C., Liao, M., Xie, Y., & Yang, J. (2023) · Chemistry Letters · doi:10.1246/cl.230280
Glycosidase-Activated H2s Donors to Enhance Chemotherapy EfficacyPreprint
Ye, Z., Li, J., Shi, J., Song, Y., Liu, Y., & Hou, J. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4666184
Enzyme-mediated activation of prodrugs
D’Agostino, I., Carradori, S., & Motta, C. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15635-9.00024-9
Pelageev, D. N., Sabutski, Y. E., Kovach, S. M., Balaneva, N. N., Menchinskaya, E. S., Chingizova, E. A., Burylova, A. L., & Ануфриев, В. Ф. (2025) · Marine Drugs · doi:10.3390/md23030117
“…40%), the yields could be considered good. e ff ect are undergoing advanced clinical trials, while many others are in preclinical development [32–34]. thiacarpine molecules and the possibility of its reduction in living cells, the mercapto derivatives formed as a result of this reduction are…”
On‐Membrane Supramolecular Assemblies Serving as Bioorthogonal Gating for Melphalan
Xu, H., Yao, Q., Hu, X., Zheng, D., Ren, C., Ren, Z., & Gao, Y. (2025) · Angewandte Chemie · doi:10.1002/ange.202502922
Busenbender, T., Pelageev, D. N., Hauschild, J., Kaune, M., Boeckelmann, L., Krisp, C., Elsesy, M. E., Zielinski, A., Mair, T., Riedner, M., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0955 · Cited by 1
Development of Antibody-polymer Conjugates for the Treatment of Intractable Cancers
Mochida, Y. (2025) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.24-00186-2
Glycoconjugates of polyamine metal complexes in cancer diagnosis and therapy
Осипов, В. Н., & Khachatryan, D. S. (2025) · Russian Chemical Bulletin · doi:10.1007/s11172-025-4617-3
Mannose‐Inspired Mesoionic Carbenes: Building Antitumor Palladium(II) Allyl Complexes
Tonon, G., Scianna, M., Caligiuri, I., Rizzolio, F., Visentin, F., & Scattolin, T. (2025) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202500382
Recent Advancements in Prodrug Strategies for Targeted Cancer Therapy
Lee, C. B., Tenora, L., Ranjit, A., Tenorová, K., & Rais, R. (2025) · Progress in drug research · doi:10.1007/978-3-032-00796-4_14
Engineered multifunctional carbon nanotube-doxorubicin conjugates for pH-triggered drug release
Alotaibi, L., Alshaikh, M. A., Alamery, S. F., Alsolami, A., Alotaibi, K. M., & Alswieleh, A. M. (2025) · Materials Research Express · doi:10.1088/2053-1591/ae0f80
Efficient Synthesis of Quinone-Based Glycohybrids
Sharma, S., Yadav, Y., Kumar, R., & Sagar, R. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810276125010007
Glycosylated β-C₃N₄ carbon nanodots for warburg effect-driven photothermal therapy of tumors
Cillari, R., Sciortino, A., Popescu, R., Rubino, R., Eggeler, Y. M., Cannas, M., Messina, F., Cavallaro, G., & Mauro, N. (2026) · Surfaces and Interfaces · doi:10.1016/j.surfin.2026.108792 · Cited by 3
“However, despite its potential, the use of C6-glucose derivatives has been little researched, with only a few studies about 18 F-labeled 6-fluoro-6-deoxy-D -glucose and glucose-drug conjugates re-ported in the literature [30].”
Development of Glycoconjugated MAGL Inhibitors with Glucose-Dependent Antiproliferative Activity
Bononi, G., Bertini, F., Masoni, S., Stefano, M. D., Mosca, R., Felice, F., Signore, G., Minutolo, F., Granchi, C., Tuccinardi, T., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062666 · Cited by 1
“The glucopyranose unit was selected as a glucose mimic, since it has been widely demonstrated that it can be potentially recognized by the glucose transporters (GLUTs) [48].”
Advances in Chemotherapeutic Potential of Glycoconjugates against Cancer
Kumar, R., Singh, A., Mazumder, A., Salahuddin, S., & Singh, N. (2026) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206401396251204070919
Synthèse de nouveaux phosphinosucres et pseudo-disaccharides à activité anticancéreuse
Babouri, R. (2016) · theses.fr (ABES) · doi:10.70675/5d7edc07z5048z4f15zb25az6f7b97a3f9f7
Functionalized-Cucurbit[n]urils : advanced drug carriers
Yang, X. (2020) · theses.fr (ABES) · doi:10.70675/df130d6bzf182z45e3zab34z746fb6b378fc
Dupommier, D. (2020) · theses.fr (ABES) · doi:10.70675/188dca62z7698z4e25z960bz315df7f39c28 · Cited by 1
Design and preparation of degradable organosilica particles for biomedical applications
Picchetti, P. (2020) · theses.fr (ABES) · doi:10.70675/896602b9z08abz493bz9890z6cf8945bf0b3
Mathieu, C. (2021) · theses.fr (ABES) · doi:10.70675/22a753dcze788z44dfz8a6az8a41b201d605
Singh, K., Shukla, A., Bablu, B., Dubey, M., Khanna, A., & Sagar, R. (2026) · Synlett · doi:10.1055/a-2863-4671
Ampadu, F. A., Patil, N. Y., Eeda, V., Rus, I., Jung, W., Abushukair, H. M., Ali, A., Aguilar-Sánchez, Y., Oh, T. G., Awasthi, V., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101886
“24,25 Although other MAP4K4 inhibitors, such as PF-6260933 and GNE-495, are under development, their in vivo efficacy in MASLD models has not been established yet.”
Toward greener pharmaceutical processing: a life-cycle strategy for sustainable healthcare
Foudah, A. I., Bakht, M. A., Ahmad, A., & Alam, A. (2026) · Green Processing and Synthesis · doi:10.1515/gps-2026-0007
Miglioli, F., Zavaroni, A., Marzano, C., Montagner, D., Carcelli, M., Gandin, V., & Rogolino, D. (2026) · ACS Omega · doi:10.1021/acsomega.6c02319
Li, H.-Y., Niu, Z., Xu, M.-Z., Wang, H., Yang, J., Liu, X., & Liang, Y. (2026) · Organic Letters · doi:10.1021/acs.orglett.6c02558
Chen, S., Zhou, Q., Xu, J., & Zhu, G. (2026) · Angewandte Chemie · doi:10.1002/ange.5354099
Chen, S., Zhou, Q., Xu, J., & Zhu, G. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.5354099
Shil, R., Roy, R., Bhattacharya, M., Ghosh, M., Dutta, S., Mandal, S., & Mondal, M. A. (2026) · New Journal of Chemistry · doi:10.1039/d6nj02640k
BindingDB Entry 50019125: Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics.
BindingDB (2024) · UC San Diego · doi:10.7270/q2w66r21
Metadata
- Authors
- Calvaresi, E. C., & Hergenrother, P. J.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Corresponding author
- Hergenrother, Paul J.
- Venue
- Chemical Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 4
- Issue
- 6
- Pages
- 2319
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- PMC
- PMC3784344
- OpenAlex
- W2110592482
- Cited by
- 398
- References
- 98
- Citations by year
- 2026: 16 · 2025: 42 · 2024: 29 · 2023: 32 · 2022: 41 · 2021: 24 · 2020: 42 · 2019: 43 · 2018: 32 · 2017: 28 · 2016: 40 · 2015: 17 · 2014: 10 · 2013: 2
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Chemical Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- University of Illinois at Urbana-Champaign
- National Cancer Institute (F30CA168323)
- National Institute of General Medical Sciences (R01GM098453)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- glycoconjugates, glucose conjugation, tumor targeting, Warburg effect, aerobic glycolysis, cytotoxin, cancer metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.